With partner Indivior exchanging a late-stage addiction programme for early-stage alternatives, 2019 did not...
OPINION
Experts Point of View
Within the record time of nine months, the Austrian government, together with experts of the Austrian...
Antimicrobial resistance (AMR) is a global threat, particularly given the modest activity in the pipeline of...
According to the FMD 2011/62, serialisation of all prescription drug packs in Europe will inevitably become a...
In February, Johnson & Johnson Innovation, JLABS opened its first European open innovation incubator, JLABs @...
Big Pharma’s interest in R&D on anti-infectives declined when other areas like oncology began offering higher...
Share
